| abstract |
(57) [Summary] [Objective] To provide a novel cerebral function-improving agent, particularly a therapeutic agent for stroke sequelae. Structure [Formula 1] [Formula (I)] (In the formula, R 1 represents a halogen atom, R 2 and R 3 each represent a hydrogen atom or a methyl group, and n represents 1 or 2, m represents 0 or 1. ) A cycloalkenone compound represented by the formula (1) and a brain function improving agent comprising the compound as an active ingredient. |